Literature DB >> 686773

Reduction of bile acid loss in cystic fibrosis by dietary means.

C A Smalley, G A Brown, M E Parkes, H Tease, V Brookes, C M Anderson.   

Abstract

On a 'normal' diet increased faecal bile acid excretion was found in 14 of 16 children with cystic fibrosis who had steatorrhoea, but excretion was normal in 2 such children without steatorrhoea. The 16 children with steatorrhoea took 3 regimens of diet and therapy: a 'normal' diet with pancreatic enzyme supplements, a diet of reduced long-chain triglycerides with added medium-chain triglycerides, and the same diet with added pancreatic enzyme supplements. On each of these three regimens steatorrhoea and faecal bile acid loss were significantly less than on no treatment, with the lowest excretions occurring on the diet of reduced long-chain triglycerides with added medium-chain triglycerides and pancreatic enzyme supplements. Although a reduction in steatorrhoea was nearly always accompanied by a decrease in bile acid excretion, the initial bile acid loss was very variable and could not be predicted for any given degree of steatorrhoea. This suggests that at least one other factor, possibly liver disease or bile acid pool size, influences bile acid loss in the faeces.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 686773      PMCID: PMC1544959          DOI: 10.1136/adc.53.6.477

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  19 in total

1.  ENZYMATIC DETERMINATION AND THIN-LAYER CHROMATOGRAPHY OF BILE ACIDS IN BLOOD.

Authors:  T IWATA; K YAMASAKI
Journal:  J Biochem       Date:  1964-11       Impact factor: 3.387

2.  A distinctive type of biliary cirrhosis of the liver associated with cystic fibrosis of the pancreas; recognition through signs of portal hypertension.

Authors:  W A BLANC; P A DI SANT'AGNESE
Journal:  Pediatrics       Date:  1956-09       Impact factor: 7.124

3.  Hepatic cirrhosis associated with fibrocystic disease of the pancreas; clinical and pathological reports of five patients.

Authors:  R WEBSTER; H WILLIAMS
Journal:  Arch Dis Child       Date:  1953-10       Impact factor: 3.791

4.  Aspects of bile acid metabolism in cystic fibrosis.

Authors:  M C Goodchild; G M Murphy; A M Howell; S A Nutter; C M Anderson
Journal:  Arch Dis Child       Date:  1975-10       Impact factor: 3.791

5.  Coeliac disease; gastrointestinal studies and the effect of dietary wheat flour.

Authors:  C M ANDERSON; J M FRENCH; H G SAMMONS; A C FRAZER; J W GERRARD; J M SMELLIE
Journal:  Lancet       Date:  1952-04-26       Impact factor: 79.321

6.  The quantitative determination of fecal bile acids in children by the enzymatic method.

Authors:  A M Weber; L Chartrand; G Doyon; S Gordon; C C Roy
Journal:  Clin Chim Acta       Date:  1972-07       Impact factor: 3.786

7.  Bile acid metabolism and hepatic disease following small bowel bypass for obesity.

Authors:  H P Sherr; P P Nair; J J White; J G Banwell; D H Lockwood
Journal:  Am J Clin Nutr       Date:  1974-12       Impact factor: 7.045

8.  Portal hypertension in cystic fibrosis.

Authors:  K R Tyson; S R Schuster; H Shwachman
Journal:  J Pediatr Surg       Date:  1968-04       Impact factor: 2.545

9.  Primate biliary physiology. X. Effects of diet and fasting on biliary lipid secretion and relative composition and bile salt metabolism in the rhesus monkey.

Authors:  R N Redinger; A H Hermann; D M Small
Journal:  Gastroenterology       Date:  1973-04       Impact factor: 22.682

10.  Minimal bile acid malabsorption and normal bile acid breath tests in cystic fibrosis and acquired pancreatic insufficiency.

Authors:  R J Roller; F Kern
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

View more
  7 in total

Review 1.  Rationale of modern dietary recommendations in cystic fibrosis.

Authors:  J M Littlewood; A MacDonald
Journal:  J R Soc Med       Date:  1987       Impact factor: 5.344

2.  Effect of dietary fat and residues on fecal loss of sterols and on their microbial degradation in cystic fibrosis.

Authors:  C Leroy; G Lepage; C L Morin; J M Bertrand; O Dufour-Larue; C C Roy
Journal:  Dig Dis Sci       Date:  1986-09       Impact factor: 3.199

Review 3.  Cystic fibrosis--a gastroenterological cornucopia.

Authors:  P L Zentler-Munro
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

4.  Intestinal bile acid malabsorption in cystic fibrosis.

Authors:  S O'Brien; H Mulcahy; H Fenlon; A O'Broin; M Casey; A Burke; M X FitzGerald; J E Hegarty
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

5.  Evaluation of an oral ursodeoxycholic acid load in the assessment of bile acid malabsorption in cystic fibrosis.

Authors:  C Colombo; A Roda; E Roda; L Piceni Sereni; D Maspero; A M Giunta; L Barbara
Journal:  Dig Dis Sci       Date:  1983-04       Impact factor: 3.199

6.  Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency.

Authors:  N Peretti; V Marcil; E Drouin; E Levy
Journal:  Nutr Metab (Lond)       Date:  2005-05-03       Impact factor: 4.169

7.  Ileal mucosal bile acid absorption is increased in Cftr knockout mice.

Authors:  M Stelzner; S Somasundaram; S P Lee; R Kuver
Journal:  BMC Gastroenterol       Date:  2001-10-15       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.